Gidday me ol mate. I have been a grizzly bear based on TA. Unfortunatly I got a brand new fresh perspective on the importance of this CX bladder test over the weekend...I am sure you can read between the lines. Anyway we will see how things go with powerful antibiotics.
It is very encouranging that such an advanced non-invasive test is available to patients in selected DHB's of which I'm in one with the Waitemata DHB.
Anyway...looking at this with a fresh set of eyes its clear the stock built a base in the 60 cent range last year before accelerating away to perhaps unrealistic level's late last year / early this year. Its clear "Mr Market" thought the stock was worth 60 cents before signing up 4 major contracts in the U.S. so maybe, just maybe, although it looks terrible from a technical perspective, we are starting to see some value around these level's (late 70's). Anyway I dipped my toe in the water at 77 cents. It could be a takeover target, I see downside as limited to 60 cents which isn't a lot of downside from where we are now. Sales will come, this looks like a remarkable product.
PEB was $1.11 less than 1 month ago...surely capitulation is coming to an end ???